EC4 COST-EFFECTIVENESS AND COST-UTILITY OF RITUXIMAB MAINTENANCE THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA IN FRENCH SETTING
Abstract
Authors
A Pacull C Coudray-Omnes P Brice E Deconinck C Le Pen H Miadi-Fargier